Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age
Authors:
- Joan Puig-BarberàJPJoan Puig-Barberà
- Javier Diez-DomingoJDJavier Diez-Domingo
- Santiago Pérez HoyosSHSantiago Pérez Hoyos
- Ángel Belenguer VareaÁVÁngel Belenguer Varea
- David González VidalDVDavid González Vidal
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-AnalysisGerontology, 2003
- Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the ElderlyNew England Journal of Medicine, 2003
- Influence of High‐Risk Medical Conditions on the Effectiveness of Influenza Vaccination among Elderly Members of 3 Large Managed‐Care OrganizationsClinical Infectious Diseases, 2002
- A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the communityVaccine, 2002
- The Impact of Influenza Epidemics on HospitalizationsThe Journal of Infectious Diseases, 2000
- Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderlyVaccine, 1999
- The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the CommunityNew England Journal of Medicine, 1994
- The impact and cost of influenza in the elderlyArchives of internal medicine (1960), 1993
- Antibody induction by influenza vaccines in the elderly: a review of the literatureVaccine, 1989
- Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.American Journal of Public Health, 1986